What's In Store For Jounce (JNCE) This Earnings Season?

 | Feb 19, 2020 10:31PM ET

We expect investors to focus on pipeline updates when Jounce Therapeutics, Inc. (NASDAQ:JNCE) reports fourth-quarter 2019 results.

Shares of the company have gained 43.7% in the past year against the industry ’s 2.6% decline.